Osiris Therapeutics Inc. has hired a new CEO — its fourth since February 2016. Linda Palczuk, 55, will start in the position July 10, replacing Interim CEO David A. Dresner. She takes over a company that has been plagued by a slumping stock price, a federal investigation into reporting of its financial statements and management shakeups. Columbia-based Osiris, which develops drugs and medical treatments using stem cells, was delisted from the NASDAQ composite earlier this year after repeatedly…
from http://www.bizjournals.com/baltimore/news/2017/06/26/osiris-therapeutics-names-new-ceo-again.html?ana=RSS%26s=article_search
via http://baltimorecheckbook.tumblr.com/post/162283333427
No comments:
Post a Comment